GR3021097T3 - Homobifunctional agents for coupling enzymes and the like to antibodies and the like. - Google Patents

Homobifunctional agents for coupling enzymes and the like to antibodies and the like.

Info

Publication number
GR3021097T3
GR3021097T3 GR960402457T GR960402457T GR3021097T3 GR 3021097 T3 GR3021097 T3 GR 3021097T3 GR 960402457 T GR960402457 T GR 960402457T GR 960402457 T GR960402457 T GR 960402457T GR 3021097 T3 GR3021097 T3 GR 3021097T3
Authority
GR
Greece
Prior art keywords
intrinsic factor
group
disclosed
solution
purified
Prior art date
Application number
GR960402457T
Other languages
English (en)
Inventor
Christopher Bieniarz
Christopher Welch
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of GR3021097T3 publication Critical patent/GR3021097T3/el

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G01N33/567—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds utilising isolate of tissue or organ as binding agent
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/06—Enzymes or microbial cells immobilised on or in an organic carrier attached to the carrier via a bridging agent
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/82—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving vitamins or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GR960402457T 1990-10-22 1996-09-19 Homobifunctional agents for coupling enzymes and the like to antibodies and the like. GR3021097T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60079590A 1990-10-22 1990-10-22
PCT/US1991/007640 WO1992007268A1 (en) 1990-10-22 1991-10-18 Homobifunctional agents for coupling enzymes and the like to antibodies and the like

Publications (1)

Publication Number Publication Date
GR3021097T3 true GR3021097T3 (en) 1996-12-31

Family

ID=24405079

Family Applications (1)

Application Number Title Priority Date Filing Date
GR960402457T GR3021097T3 (en) 1990-10-22 1996-09-19 Homobifunctional agents for coupling enzymes and the like to antibodies and the like.

Country Status (12)

Country Link
US (1) US5380873A (el)
EP (1) EP0555336B1 (el)
JP (2) JP3360174B2 (el)
KR (1) KR930702683A (el)
AT (1) ATE140795T1 (el)
AU (1) AU657284B2 (el)
CA (1) CA2094397C (el)
DE (1) DE69121108T2 (el)
DK (1) DK0555336T3 (el)
ES (1) ES2092579T3 (el)
GR (1) GR3021097T3 (el)
WO (1) WO1992007268A1 (el)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2157767A1 (en) * 1993-03-09 1994-09-15 Elaine M. Brate Genetically engineered enzymes and their conjugates for diagnostic assays
US5548064A (en) * 1993-05-24 1996-08-20 Biotech Australia Pty Limited Vitamin B12 conjugates with EPO, analogues thereof and pharmaceutical compositions
US6306665B1 (en) * 1999-10-13 2001-10-23 A-Fem Medical Corporation Covalent bonding of molecules to an activated solid phase material
US7193065B2 (en) * 2001-07-13 2007-03-20 Roche Diagnostics Operations, Inc. Protease inhibitor conjugates and antibodies useful in immunoassay
EP1877101B1 (en) 2005-04-28 2016-11-16 Ventana Medical Systems, Inc. Enzymes conjugated to antibodies via a peg heterobifuctional linker
JP4793714B2 (ja) * 2005-05-19 2011-10-12 独立行政法人産業技術総合研究所 新規クロスリンカー化合物
JP5199880B2 (ja) 2005-11-23 2013-05-15 ベンタナ・メデイカル・システムズ・インコーポレーテツド 分子コンジュゲート
WO2008136769A1 (en) * 2007-05-03 2008-11-13 Nanyang Technological University Online contaminant detection and removal system

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU626809B2 (en) * 1987-10-30 1992-08-13 Abbott Laboratories Heterobifunctional coupling agents
US5066490A (en) * 1988-06-01 1991-11-19 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Protein crosslinking reagents cleavable within acidified intracellular vesicles
US5104815A (en) * 1988-10-11 1992-04-14 Abbott Laboratories Assay for cobalamins
ES2104566T3 (es) * 1989-03-10 1997-10-16 Hoffmann La Roche Reactivos para la determinacion de drogas.

Also Published As

Publication number Publication date
EP0555336B1 (en) 1996-07-24
EP0555336A4 (en) 1994-10-12
KR930702683A (ko) 1993-09-09
DE69121108D1 (de) 1996-08-29
EP0555336A1 (en) 1993-08-18
ES2092579T3 (es) 1996-12-01
AU657284B2 (en) 1995-03-09
DK0555336T3 (da) 1996-11-25
JP2000229926A (ja) 2000-08-22
AU8905991A (en) 1992-05-20
DE69121108T2 (de) 1997-02-27
CA2094397A1 (en) 1992-04-23
JP3488670B2 (ja) 2004-01-19
CA2094397C (en) 2005-10-04
JPH06502411A (ja) 1994-03-17
WO1992007268A1 (en) 1992-04-30
JP3360174B2 (ja) 2002-12-24
US5380873A (en) 1995-01-10
ATE140795T1 (de) 1996-08-15

Similar Documents

Publication Publication Date Title
Campbell Human leukocyte elastase, cathepsin G, and lactoferrin: family of neutrophil granule glycoproteins that bind to an alveolar macrophage receptor.
DE3067935D1 (en) Antitumor protein hybrid and process for the preparation thereof
EP0236987A3 (en) Chemically modified protein and production thereof
ES8700672A1 (es) Un procedimiento para la preparacion de derivados de amino alquilentio-alquilentiofosfonatos.
IE890233L (en) Paramagnetic compounds
NZ239617A (en) Pharmaceutical compositions containing cross-linked homoconjugated monoclonal antibodies having at least two igg antibodies which bind to the same determinant
FI960379A0 (fi) Lasikuitukoostumuksia
GR3021097T3 (en) Homobifunctional agents for coupling enzymes and the like to antibodies and the like.
WO1992000759A3 (en) Stabilized therapeutic radiopharmaceutical complexes
FR2567596B1 (fr) Agrafe pour l'assemblage de pieces, telles que des panneaux
DK656488D0 (da) Praeparat med langvarig frigivelse indeholdende 1,4-dihydropyridinforbindelser
FR2560212B1 (fr) Anticorps monoclonaux contre l'interferon a2 et hybridomes produisant de tels anticorps
DE59010462D1 (de) Neue Cobalamin-Säurehydrazide und davon abgeleitete Cobalamin-Konjugate
DE3366933D1 (en) Antithrombin-heparin complex
ES2082132T3 (es) Composicion que contiene al menos dos anticuerpos distintos o fragmentos de ellos.
DE69637524D1 (de) Das h-y antigen
FR2524991B1 (fr) Compositions d'agent de marquage, renfermant des additifs de renforcement de charge, constitues d'acides para-halophenylcarboxyliques
EP0601318A3 (de) Verfahren zur Herstellung von Konjugaten aus einem spezifischen Bindungspartner und einem kohlenhydrathaltigen Protein.
Hudson et al. The use of column-bound B lymphocytes for absorption of antisera to T lymphocyte antigens
Rao Cationic dependency of high affinity prostaglandin F2α receptors in bovine corpus luteum cell membranes
DE3468324D1 (en) Specific antibody to the native form of 2'5'-oligonucleotides, the method of preparation and the use as reagents in immunoassays or for binding 2'5'-oligonucleotides in biological systems
Harmon Purification of antibodies against biotin on lipoic acid-sepharose
AU1780988A (en) Glycidyl methacrylate grafted epdm modifiers in fiber reinforced polyester compositions
Landen et al. C3-Mediated Cytoadherence: II. Dependence of Cell Attachment on Similar Topographic Distribution of the Receptors (for C3) and of the Ligands (C3/C3b)
KR900004975A (ko) 해도형 복합섬유의 제조방법